Ryan Henrici M.D.

Ryan Henrici MD PhD serves as Vice President of Discovery Medicine at BigHat Biosciences since January 2020, overseeing global Discovery Biology and Translational Research strategy, pipeline management, and new program evaluation for next-generation antibody therapeutics. Prior roles include Senior Director of Translational Research and Director of Translational Research, focusing on therapeutic program strategy, target identification, and antibody optimization across multiple therapeutic areas. Additionally, Ryan holds an Adjunct Associate Professorship at the University of Pennsylvania School of Medicine, teaching various subjects, and serves as a Clinical Investigator at Indiana University School of Medicine, co-leading a clinical study on antimalarial treatment outcomes in children with sickle cell anemia. Education includes an M.D. from the University of Pennsylvania School of Medicine, a Ph.D. in Infectious and Tropical Disease from the London School of Hygiene and Tropical Medicine, and a BSc (Hons) in Biochemistry and Molecular Biology from Schreyer Honors College at Penn State.